SCHEMBL27474216

SCHEMBL27474216

CNC1=CC(NC)(NC)Nc2c(F)cc(-c3cccc([N+](=O)[O-])c3)cc21

nearest known ligand 0.46

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 9/20 0.46
▸ TDP2 O95551 3/20 0.42
▸ AKR1C3 P42330 2/20 0.38
▸ AKR1C2 P52895 2/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ NPY5R Q15761 1/20 0.37
▸ MAPT P10636 2/20 0.35
▸ GSK3B P49841 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27477006 0.87 PGR (0.46) PGRTDP2MAPTGSK3B
SCHEMBL27493196 0.86 PGR (0.45) PGRTDP2NPC1RAB9AMAPT
SCHEMBL27479855 0.84 PGR (0.60) PGRTDP2NPC1MAPT
SCHEMBL4179783 0.78 PGR (0.67) PGRTDP2AKR1C3AKR1C2NPC1
SCHEMBL27474213 0.76 PGR (0.43) PGRTDP2NPC1MAPTGSK3B
SCHEMBL4186117 0.74 PGR (0.47) PGRTDP2AKR1C3AKR1C2NPC1
SCHEMBL27494363 0.73 PGR (0.44) PGRTDP2AKR1C3AKR1C2NPC1
SCHEMBL27491175 0.73 PGR (0.46) PGRTDP2NPC1RAB9AMAPT
SCHEMBL4180267 0.66 PGR (0.70) PGRTDP2AKR1C3AKR1C2MAPT
SCHEMBL6738366 0.65 TSHR (0.76) PGRNPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1172917-C Steroid receptor modulator compounds and methods ��λ��ҩ��ɷ����޹�˾ 2004-10-27 — — CN claimed
CN-1626534-A Steroid receptor modulator compounds and methods LIGAND PHARM INC (US) 2005-06-15 — — CN disclosed
CN-1172917-C Steroid receptor modulator compounds and methods ��λ��ҩ��ɷ����޹�˾ 2004-10-27 — — CN disclosed
CN-1175247-A Steroid receptor modulator compounds and methods LIGAND PHARM INC (US) 1998-03-04 — — CN disclosed
Send feedback